Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SC 13G Stake Amended Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change
  6. 4 Planned sale Head of Development sold 431 shares at $204.22 ($88,019)
  7. 144 Insider Sale of Securities
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 8-K Event Material agreement · Agreement ended · New debt or obligation
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 4 Grant or award Director acquired 1,340 shares (grant or award)
  14. 4 Grant or award Director acquired 1,340 shares (grant or award)
  15. 4 Grant or award Director acquired 1,340 shares (grant or award)
  16. 4 Grant or award Director acquired 1,340 shares (grant or award)
  17. 4 Grant or award Director acquired 1,340 shares (grant or award)
  18. 4 Grant or award Director acquired 1,340 shares (grant or award)
  19. 4 Grant or award Director acquired 1,340 shares (grant or award)
  20. 4 Grant or award Director acquired 1,785 shares (grant or award)

Page 9 of 137 · 2,721 filings